Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
Why Avenue Therapeutics (ATXI) Stock Is Falling Sharply
Avenue Therapeutics (NASDAQ:ATXI) shares are trading lower by 20.7% to $4.92 during Monday's session after the company announced the exercise of warrants for $4.4 million in gross proceeds.
Avenue Therapeutics（纳斯达克股票代码：ATXI）在周一的交易中股价下跌20.7％，至4.92美元，此前该公司宣布行使认股权证，总收益为440万美元。
These warrants were issued at different times with various exercise prices, but the warrant holders have agreed to exercise them at a reduced price of $6.20 per share. The company expects to receive approximately $4.4 million in gross proceeds from this exercise.
这些认股权证是在不同的时间发行的，行使价格各不相同，但认股权证持有人同意以每股6.20美元的较低价格行使这些认股权证。该公司预计将从此次活动中获得约440万美元的总收益。
In return for exercising the warrants, Avenue will issue new unregistered Series C and Series D warrants to the warrant holders, each allowing them to purchase up to 689,680 shares of common stock at an exercise price of $6.20 per share.
作为行使认股权证的回报，Avenue将向认股权证持有人发行新的未注册的C系列和D系列认股权证，每份认股权证允许他们以每股6.20美元的行使价购买多达689,680股普通股。
The new Series C warrants will be exercisable immediately and valid for five years, while the Series D warrants will be exercisable immediately but valid for eighteen months. The transaction is expected to close around May 1, 2024, subject to standard closing conditions.
新的C系列认股权证可立即行使，有效期为五年，而D系列认股权证可立即行使，但有效期为十八个月。该交易预计将于2024年5月1日左右完成，但须遵守标准成交条件。
Should I Sell My ATXI Stock?
我应该卖出我的 ATXI 股票吗？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在决定持有或出售股票时，投资者应考虑其时间范围、未实现收益和总回报。
Shares of Avenue Therapeutics have decreased by 93.29% in the past year. An investor who bought shares of Avenue Therapeutics at the beginning of the year would take a loss of $7.05 per share if they sold it today. The stock has fallen 56.03% over the past month, meaning an investor who bought shares on Mar. 1 would see a capital loss of $6.95.
在过去的一年中，Avenue Therapeutics的股价下跌了93.29％。年初购买Avenue Therapeutics股票的投资者如果今天出售股票，则每股亏损7.05美元。该股在过去一个月中下跌了56.03％，这意味着在3月1日购买股票的投资者将遭受6.95美元的资本损失。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Avenue Therapeutics stock currently has an RSI of 27.91, indicating oversold conditions.
投资者也可以考虑市场动态。相对强弱指数可用于表明股票是超买还是超卖。Avenue Therapeutics股票目前的相对强弱指数为27.91，这表明存在超卖情况。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
要访问高级制图和分析工具以及股票数据，请查看 Benzinga PRO。免费试用。
ATXI has a 52-week high of $93.75 and a 52-week low of $4.77.
ATXI的52周高点为93.75美元，52周低点为4.77美元。
译文内容由第三方软件翻译。